Merz Therapeutics Names Dan Staner President of Europe
Frankfurt, Germany – January 30, 2026 — Merz Therapeutics has announced the appointment of Dan Staner as President, Region...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Frankfurt, Germany – January 30, 2026 — Merz Therapeutics has announced the appointment of Dan Staner as President, Region...
Ingelheim, Germany, November 28, 2025 Boehringer Ingelheim has announced a strategic leadership expansion with the appointment of Harsha Deshmukh...
Kenilworth, N.J., October 29, 2025— Merck & Co., Inc. (NYSE: MRK), known as MSD outside the U.S. and Canada,...
